A detailed history of Allen Capital Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Allen Capital Group, LLC holds 864 shares of LLY stock, worth $687,458. This represents 0.09% of its overall portfolio holdings.

Number of Shares
864
Previous 688 25.58%
Holding current value
$687,458
Previous $622,000 22.99%
% of portfolio
0.09%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $135,896 - $168,963
176 Added 25.58%
864 $765,000
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $84,809 - $106,357
117 Added 20.49%
688 $622,000
Q1 2024

Apr 15, 2024

BUY
$592.2 - $792.28 $79,354 - $106,165
134 Added 30.66%
571 $444,000
Q4 2023

Jan 30, 2024

BUY
$525.19 - $619.13 $229,508 - $270,559
437 New
437 $254,000
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $190,098 - $236,244
-810 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$224.85 - $279.04 $182,128 - $226,022
810 New
810 $224,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Allen Capital Group, LLC Portfolio

Follow Allen Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allen Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allen Capital Group, LLC with notifications on news.